These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5386314)

  • 1. [Phosphocreatinekinase as a sign of muscular damage].
    Schaposnik F; Salvioli MV; Laguens R; Neumann M; Cacciatore J
    Prensa Med Argent; 1969 Jun; 56(14):615-8. PubMed ID: 5386314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significances of the elevated activity of serum creatine phosphokinase and transaminase in progressive muscular dystrophy].
    Kondo F; Ikeda M; Abe E; Mue S
    Iryo; 1966 Jul; 20(7):683-93. PubMed ID: 5981769
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined use of anabolic steroids and digitoxin in progressive muscular dystrophy].
    Yamamoto H; Sugita H; Furukawa T
    Iryo; 1966 Jul; 20(7):704-8. PubMed ID: 5981771
    [No Abstract]   [Full Text] [Related]  

  • 4. Alcohol and Serum creatinine kinase levels.
    Lane RJ; Radoff FM
    Ann Neurol; 1981 Dec; 10(6):581-3. PubMed ID: 7325610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of serum creatine phosphokinase and its isoenzymes in various muscular diseases].
    László A; Heiner L
    Orv Hetil; 1980 Jan; 121(3):139-40. PubMed ID: 7366978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serial colorimetric microdetermination of serum creatine kinase and its clinical and biological importance].
    Menaché R; Gaist L
    Boll Soc Ital Biol Sper; 1967 Jan; 43(1):39-41. PubMed ID: 6048339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum creatine phosphokinase in various muscular diseases seen in the field of orthopedic surgery].
    Iwamoto A
    Igaku Kenkyu; 1969 May; 39(2):108-21. PubMed ID: 5389323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histopathological and enzyme histochemical studies on experimentally induced muscular dystrophy in the rabbit].
    den Hartog Jager WA; Meijer AE; de Jong JM
    Ned Tijdschr Geneeskd; 1968 Mar; 112(11):543-4. PubMed ID: 5664442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy.
    Hetnarska L
    Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of muscular dystrophy. 2. Enzyme activities].
    Imai H; Yamagi K; Asano T; Niwa S; Kato Y
    Iryo; 1967 Jul; 21(7):854-8. PubMed ID: 5582481
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of the determination of cretaine phosphokinase activity (CPK) in certain diseases of the muscles.
    Hetnarska L
    Pol Med J; 1968; 7(3):742-6. PubMed ID: 5669716
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of creatine kinase activity using bioluminescence].
    Kühn HJ; Theml P; Pilz D
    Psychiatr Neurol Med Psychol (Leipz); 1984 Sep; 36(9):551-5. PubMed ID: 6514867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 18. [Congenital muscular dystrophy].
    Mumenthaler M
    Z Kinderheilkd; 1969; 106(2):131-62. PubMed ID: 5802055
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on progressive muscular dystrophy. 1. Influence of the various drugs on serum enzyme activity and the degree of disability].
    Kanno M; Annaka S; Sato N; Shinoda M
    Iryo; 1968 Dec; 22(12):1364-71. PubMed ID: 5717702
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.